Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors

		Keywords:

		Phase:		Phase 2

		Treatment ID#s:		VT1882 NCT00039494

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: Recurrent: Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed Histologically confirmed diagnosis of 1 of the following: Glioblastoma multiforme (grade 4 astrocytoma) Gliosarcomas Other grade 4 astrocytoma variants (e.g., giant cell) Must be enrolled at least 1 week, but no more than 4 weeks, after prior biopsy or surgery

		Last Updated:		09/30/2008

		Tumor Types:		Anaplastic Astrocytoma Any Malignant Brain Tumor Glioblastoma Multiforme Gliosarcoma


		Comments:

		Treatment Type:		Chemotherapy Radiation.

		Contact:		University of Virginia Health System David Schiff, MD Co-Director, Division of Neuro-Oncology Department of Neurology Box 800432 Charlottesville, VA 22908-0432 Phone:434-982-4415 Fax: 434-982-4467 Click here to send an email Website: www.uvabraintumor.com

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By